应用溶栓药物治疗急性心梗已有二十多年。溶栓疗法有着充分的病理生理学的依据,广泛的协作研究证明这种疗法确实有效。临床研究和动物实验证明,冠脉血流的恢复使患者的死亡率降低;溶栓治疗开始越早,疗效越好;然而即使再灌注发生较迟,只要冠脉血流得到持久的恢复,与冠脉持续 Thrombolytic drugs have been used in the treatment of acute myocardial infarction for more than 20 years. Thrombolytic therapy has ample evidence of its pathophysiology, and extensive collaborative research has proved that the therapy is effective. Clinical studies and animal experiments show that the restoration of coronary blood flow to reduce the mortality of patients; thrombolytic therapy started earlier, the better the effect; however, even if the reperfusion occurred later, as long as the coronary blood flow sustained recovery, and Coronary artery continued